A
Andrea L. Harabin
Researcher at National Institutes of Health
Publications - 13
Citations - 5791
Andrea L. Harabin is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lung injury & Clinical trial. The author has an hindex of 11, co-authored 13 publications receiving 5023 citations. Previous affiliations of Andrea L. Harabin include University of Colorado Denver.
Papers
More filters
Journal ArticleDOI
Comparison of two fluid-management strategies in acute lung injury.
Herbert P. Wiedemann,Arthur P. Wheeler,Gordon R. Bernard,B. Taylor Thompson,Douglas Hayden,Ben deBoisblanc,Alfred F Connors,R. Duncan Hite,Andrea L. Harabin +8 more
TL;DR: A conservative strategy of fluid management using explicit protocols applied for seven days in 1000 patients with acute lung injury improved the chances of death at 60 days and the conservative strategy improved fluid balance during the first seven days.
Journal ArticleDOI
Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders' conference.
Dale M. Needham,Judy E. Davidson,Henry Cohen,Ramona O. Hopkins,Craig R. Weinert,Hannah Wunsch,Christine Zawistowski,Anita Bemis-Dougherty,Susan C Berney,O. Joseph Bienvenu,Susan Brady,Martin B. Brodsky,Linda Denehy,Doug Elliott,Carl Flatley,Andrea L. Harabin,Christina Jones,Deborah Louis,Wendy Meltzer,Sean R. Muldoon,Jeffrey B. Palmer,Christiane Perme,Marla Robinson,David M. Schmidt,Elizabeth Scruth,Gayle R. Spill,C. Porter Storey,Marta L. Render,John Votto,Maurene A. Harvey +29 more
TL;DR: Improving care for intensive care survivors and their families requires collaboration between practitioners and researchers in both the inpatient and outpatient settings, and three major themes emerged from the conference.
Journal ArticleDOI
Future research directions in acute lung injury: Summary of a National Heart, Lung, and Blood Institute Working Group
Michael A. Matthay,Guy A. Zimmerman,Charles T. Esmon,Jahar Bhattacharya,Barry Coller,Claire M. Doerschuk,Joanna Floros,Michael A. Gimbrone,Eric A. Hoffman,Rolf D. Hubmayr,Mark Leppert,Sadis Matalon,Robert S. Munford,Polly E. Parsons,Arthur S. Slutsky,Kevin J. Tracey,Peter A. Ward,Dorothy B. Gail,Andrea L. Harabin +18 more
TL;DR: Improved understanding of disease heterogeneity through use of evolving biologic, genomic, and genetic approaches should provide major new insights into pathogenesis of ALI.
Journal ArticleDOI
Beyond Mortality: Future Clinical Research in Acute Lung Injury
Roger G. Spragg,Gordon R. Bernard,William Checkley,J. Randall Curtis,Ognjen Gajic,Gordon H. Guyatt,Jesse B. Hall,E. Israel,Manu Jain,Dale M. Needham,Adrienne G. Randolph,Gordon D. Rubenfeld,David A. Schoenfeld,B. Taylor Thompson,Lorraine B. Ware,Duncan Young,Andrea L. Harabin +16 more
TL;DR: The workshop assessed the current state of clinical research addressing ALI, identified research needs, and recommended: continued performance of trials evaluating treatments of patients with ALI; development of strategies to perform ALI prevention trials; and development of a standardized format for reporting methods, endpoints, and results of ALI trials.
Journal ArticleDOI
Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome
Herbert P. Wiedemann,Alejandro C. Arroliga,John Komara,V. A. Denver,Carolyn H. Welsh,William J. Fulkerson,Neil R. MacIntyre,Lee Mallatratt,Mark Sebastian,Robert Sladen,Carroll Wilcox,Roy G. Brower,David C. Thompson,Alan H. Morris,Terry Clemmer,Robin M Davis,James Orme,Charles B. Lawton,Janice D'Hulst,Carolyn Smith,Thomas Jefferson,Jonathan E. Gottlieb,Aimee Girod,M. A. Matthay,Brian Daniel,Richard Kallet,John M. Luce,Michael A. Gryzner,Edward Abraham,Fran Piedalue,Dawn Kalous,Christine Walberg,John D. Lockrem,Robert C. McIntyre,Polly E. Parsons,Chris Stevens,Henry J. Silverman,Wanda Corral,Galen B. Toews,Deborah Arnoldi,Robert H. Bartlett,Ron Dechert,Charles Watts,Paul N. Lanken,Harry Anderson,Barbara Finkel,C. William Hanson,Leonard D. Hudson,Claudette Lee,Ronald V. Maier,Kenneth P. Steinberg,Arthur P. Wheeler,Gordon Bernard,Libby Stone,David A. Schoenfeld,B. Taylor Thompson,Marek Ancukiewicz,Douglas Hayden,Francine Molay,Nancy Ringwood,Gail Wenzlow,Gordon R. Bernard,Dorothy B. Gail,Carol H. Bosken,Andrea L. Harabin,Pamela Randall,Myron Waclawiw,Carolyn Paradise,Steven Dahlberg,Roger G. Spragg,James M. Boyett,Jason Kelley,Marion Gray Secundy,Kenneth Leeper,Arthur S. Slutsky,Thomas M. Hyera,Scott S. Emerson,Joe G N Garcia,Susan K. Pingleton,Michael D. Shasby,William J. Sibbald,Michael Matthay +81 more
TL;DR: There was no evidence that lisofylline had beneficial effects in the treatment of established ALI/ARDS and the trial was stopped by the Data Safety Monitoring Board for futility at the first scheduled interim analysis.